Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population‐based cohort
Authors:
- 1 February 2002
- journal article
- research article
- Published by Wiley in Journal of Internal Medicine
- Vol. 251 (2) , 102-110
Abstract
Karvonen J, Kauma H, Kervinen K, Rantala M, Ikäheimo M, Päivänsalo M, Savolainen MJ, Kesäniemi YA (University of Oulu, Oulu; Finland). Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population‐based cohort. J Intern Med 2002; 251: 102–110. Objective. Decreased production of endothelial nitric oxide (NO) is associated with different cardiovascular pathology. We studied the association between the Glu298Asp polymorphism of the NO producing gene, endothelial nitric oxide synthase (eNOS), and hypertension, left ventricular mass (LVM) and carotid artery intima‐media thickness (IMT) in a population‐based cohort of hypertensive and control subjects. Design. Cross‐sectional case–control study. Setting. District around Oulu University Hospital, Northern Finland. Subjects and methods. The study population consisted of 600 middle‐aged hypertensive subjects (300 men and 300 women) and 600 controls (300 men and 300 women) living in the City of Oulu. The hypertensive subjects were randomly selected by age stratification from the Social Insurance Institute register for reimbursement of antihypertensive medication. For each hypertensive subject, an age‐ and sex‐matched control was randomly selected from the national health register. The overall participation rate was 87.8%. In the present study a total of 1024 subjects were screened. Echocardiographic examinations were performed by a trained cardiologist and carotid ultrasonographic examinations by a trained radiologist. Results. The genotype distributions and allele frequencies between the hypertensive and control subjects and the relationship between the Glu298Asp variant and blood pressure, LVM and carotid artery IMT were determined. No differences in genotype distribution or allele frequencies were found between the hypertensive and control groups (the frequency of the Asp allele 0.299 vs. 0.288, respectively). Also, we could not find any association between the eNOS genotype and the measured cardiovascular complications. Conclusions. The Glu298Asp variant of the eNOS gene does not seem to be a major risk factor for cardiovascular alterations in the general population.Keywords
This publication has 39 references indexed in Scilit:
- NOS3 Glu298Asp Genotype and Blood Pressure Response to Endurance TrainingHypertension, 2000
- A T-786→C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene and coronary arterial vasomotilityThe American Journal of Cardiology, 2000
- Variants of renin–angiotensin system genes and echocardiographic left ventricular mass1998
- Variation at the Angiotensin-Converting Enzyme Gene and Angiotensinogen Gene Loci in Relation to Blood PressureHypertension, 1996
- Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Long-term inhibition of NO synthesis promotes atherosclerosis in the hypercholesterolemic rabbit thoracic aorta. PGH2 does not contribute to impaired endothelium-dependent relaxation.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Inhibition of low‐density lipoprotein oxidation by nitric oxide Potential role in atherogenesisFEBS Letters, 1993
- Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of a computerized analysing systemClinical Physiology and Functional Imaging, 1991
- Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide.Journal of Clinical Investigation, 1990
- Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.Journal of Clinical Investigation, 1989